Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1077235
Max Phase: Preclinical
Molecular Formula: C66H96N2O32S3
Molecular Weight: 1525.68
Molecule Type: Small molecule
Associated Items:
ID: ALA1077235
Max Phase: Preclinical
Molecular Formula: C66H96N2O32S3
Molecular Weight: 1525.68
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CN(C)c1cccc2c(S(=O)(=O)NCCSCCCCCS[C@@H]3O[C@H](CO)[C@@H](O[C@H]4O[C@H](CO)[C@@H](O[C@H]5O[C@H](CO)[C@@H](O[C@H]6O[C@H](CO)[C@@H](O[C@H]7O[C@H](CO)[C@@H](O[C@H]8O[C@H](COCc9ccc%10ccccc%10c9)[C@@H](O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O)cccc12
Standard InChI: InChI=1S/C66H96N2O32S3/c1-68(2)35-14-8-13-34-33(35)12-9-15-42(34)103(87,88)67-18-21-101-19-6-3-7-20-102-66-55(86)49(80)60(40(27-73)95-66)100-65-54(85)48(79)59(39(26-72)93-65)99-64-53(84)47(78)58(38(25-71)92-64)98-63-52(83)46(77)57(37(24-70)91-63)97-62-51(82)45(76)56(36(23-69)90-62)96-61-50(81)44(75)43(74)41(94-61)29-89-28-30-16-17-31-10-4-5-11-32(31)22-30/h4-5,8-17,22,36-41,43-67,69-86H,3,6-7,18-21,23-29H2,1-2H3/t36-,37-,38-,39-,40-,41-,43-,44+,45-,46-,47-,48-,49-,50-,51-,52-,53-,54-,55-,56-,57-,58-,59-,60-,61-,62-,63-,64-,65-,66+/m1/s1
Standard InChI Key: IHTSKBBSMJXJHZ-XUCYLINBSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1525.68 | Molecular Weight (Monoisotopic): 1524.5108 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Oka H, Koyama T, Hatano K, Terunuma D, Matsuoka K.. (2010) Simple and conveniently accessible bi-fluorescence-labeled substrates for amylases., 20 (6): [PMID:20171095] [10.1016/j.bmcl.2010.01.117] |
2. Oka H, Koyama T, Hatano K, Matsuoka K.. (2012) Synthetic studies of bi-fluorescence-labeled maltooligosaccharides as substrates for α-amylase on the basis of fluorescence resonance energy transfer (FRET)., 20 (1): [PMID:22100259] [10.1016/j.bmc.2011.10.065] |
Source(1):